Champion Homes (NYSE:SKY) entered into a definitive agreement to acquire the retail assets of Homes Direct, securing 11 high-volume sales locations to accelerate its direct-to-consumer distribution strategy across the Western U.S.
Audemars Piguet's recent collaboration with Swatch led to scuffles outside stores from New York to Paris to Milan, as crowds queued for hours to get their hands on the Royal Pop pocket watch collection. Despite criticism that the collaboration could 'cheapen' the brand, CEO Ilaria Resta says it has made AP more accessible to a younger audience, while the thing she fears most is 'irrelevance'. She spoke on 'The Pulse with Francine Lacqua' on Bloomberg TV.
Champion Homes (NYSE:SKY) reported higher net sales for both the fourth quarter and full fiscal year 2026, leveraging steady average selling prices to counter macroeconomic housing headwinds while refreshing its capital return program.
Northern Oil and Gas (NYSE:NOG) agreed to acquire an undivided 25% non-operated interest in light oil assets within Alberta’s Duvernay Shale for an initial unadjusted purchase price of CA$350 million (approximately US$259 million), marking the company’s first expansion outside of the United States.
Aurora Mobile (NASDAQ:JG) recorded its fourth consecutive quarter of positive net income during the opening three months of the year, driven by the rapid scaling of its international messaging division.
Ituran Location and Control (NASDAQ:ITRN) breached the $100 million quarterly revenue threshold for the first time in corporate history, driven by broad-based expansion across its core telematics and stolen vehicle recovery markets.
Silicom (NASDAQ:SILC) secured a design win with an unnamed Tier-1 global cybersecurity firm, establishing a new white-label switch product line aimed at displacing incumbent networking vendors.
Kura Oncology (NASDAQ:KURA) reported preliminary Phase 1a data from its FIT-001 clinical trial, showing that a combination of its next-generation farnesyl transferase inhibitor darlifarnib and adagrasib induced tumor shrinkage in 77% of evaluable patients with advanced solid tumors.
Wall Street firms are paying two highly sought-after trainers in finance $25,000 a day to tell bankers what's missing from their AI plans. Matthew Bloxham of Bloomberg Intelligence has more.
Editas Medicine (NASDAQ:EDIT) presented preclinical data for its lead in vivo gene-editing candidate, EDIT-401, demonstrating that a single dose slashed three key drivers of cardiovascular disease by 90% or more in non-human primates.
Senstar Technologies (NASDAQ:SNT) reported a minor revenue decline and swung to an operating loss for the first quarter, hampered by elongated customer procurement cycles and project delays within its core U.S. government market.
Shipments of foreign-branded mobile phones in China, including Apple's (NASDAQ:AAPL) iPhone, increased 1.8% in April compared to the same month last year, pointing to a stabilizing consumer electronics market amid intense domestic competition.
